Expert Market Research’s new report titled ‘Global Antiplatelet Drugs Market Report and Forecast 2021-2026’, gives an in-depth analysis of the global Antiplatelet Drugs market, assessing the market based on its segments such as drug, drug class, applications, different routes of administration, distribution channel and major regions. The report tracks the latest industry trends and studies their impact on the overall market. It also assesses market dynamics, covering key demand and price indicators, as well as market analysis based on SWOT and Porter’s Five Forces models.
Get Free Sample Report With TOC- https://www.expertmarketresearch.com/reports/antiplatelet-drugs-market/requestsample
Key highlights of the report include:
Market Overview (2016-2026):-
- Forecast CAGR (2021-2026): 7%
Due to increasing organic and inorganic growth within the industry, the antiplatelet drugs market is expected to grow over the forecast period. Moreover, the generic market is also growing, thus giving a boost to generic antiplatelet drug manufacturers. It is also expected that the sums invested by the companies in research and development will contribute to the sales of the antiplatelet drugs market in the future.
Industry definition and major segments
Antiplatelet drugs are incorrectly called blood thinners. They do not thin the blood but interfere with the essential blood clotting process. Clumping of blood cells is usually decreased by the antiplatelet agent, thereby reducing potentially dangerous blood clots. People at high risk of heart failure will avoid the risk of stroke and heart attack when receiving antiplatelet agents.
By Drug, the market is split into:
On the basis of drug class, the industry can be segmented into:
- Platelet aggregation inhibitors
- Platelet glycoprotein inhibitors
- Protease-activated receptor-1 antagonists
Based on the applications, the industry can be categorized into:
- Myocardial infringement
- Percutaneous Coronary Interventions
- Arterial thrombosis
- Dental surgeries
The different routes of administration of antiplatelet agents are:
The different product distribution channels are:
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
Based on Region, the market is segmented into:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
The development of the industry is mainly due to changing lifestyles, and an aging population contributes to an increasing global prevalence of heart disease. Around the world, some 15 million people a year suffer from heart attacks, according to the WHO. The big drawback hampering the growth of the market is the increasing risk of bleeding in highly complicated surgeries. The misconception of antiplatelet pharmaceuticals with blood thinners is also a major impediment to market development. The consumption of antiplatelet drugs in recent years has also been affected by side effects such as nausea, upset stomach, stomach pain, diarrhea, rash and itching. With the number of players initiating clinical trials for antiplatelet drugs, North America is the dominant region. In addition, to develop new product alternatives, many academic universities receive research grants. Kengreal, an intravenous antiplatelet drug developed by The Medicines Company, for example, has received FDA approval. As Asia-Pacific is an economically developing country, the forecast period is expected to spearhead it.
Read Full Report with TOC – https://www.expertmarketresearch.com/reports/antiplatelet-drugs-market
Main market players
The major market players are Glenmark Pharmaceuticals Ltd., Sanofi SA, Pfizer Inc., Baxter International Inc., Bayer AG, among others. The report covers market shares, capacities, plant rotations, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports and advisory services to our clients. We serve a wide clientele ranging from Fortune 1000 companies to small and medium-sized businesses. Our reports cover over 100 industries in established and emerging markets researched by our trained analysts who track the latest economic, demographic, business and market data globally.
At Expert Market Research, we tailor our approach based on the needs and preferences of our clients, providing them with valuable, actionable and up-to-date market insights, helping them realize their optimal growth potential. We offer market intelligence across a range of verticals including Pharmaceuticals, Food & Beverage, Technology, Retail, Chemicals & Materials, Energy & Mining, Packaging and farming.
We also provide state-of-the-art procurement information through our platform, https://www.procurementresource.com. Procurement Resource is a leading platform for digital procurement solutions, offering daily price tracking, market insights, supply chain insights, sourcing analytics, and procurement insights. categories with our in-depth and infallible market reports, cost of production reports, price analysis and benchmarking.
Informes de Expertos (https://informesdeexpertos.com), the Spanish variant of Expert Market Research, is a platform that offers market research and consulting services to a wide client base in Spanish-speaking countries. Focusing primarily on the Latin American and Spanish markets, our research experts provide relevant and actionable market insights and track key trends, economic developments and global trade data.
Determined to bring client satisfaction, we ensure that our tailored approach meets the client’s unique market intelligence requirements. Our syndicated and custom research reports cover a wide range of industries from pharmaceuticals and food and beverages to packaging, logistics and transportation.
Company Name: Market Research Expert
Contact:-Ian Bell, Business Advisor
Toll Free: USA +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Country: United States
At Expert Market Research, we always strive to give you the latest information. The figures in the article are only indicative and may differ from the actual report.